Podcast Summary: The Neuro Experience – “Longevity Surgeon: The Biomarkers That Predict If You'll Get Cancer or Alzheimer's”

Host: Louisa Nicola
Guest: Dr. Darshan Shah (Founder, Next Health)
Date: February 24, 2026

Episode Overview

This episode dives deeply into the convergence of longevity, advanced blood biomarker testing, preventive approaches to cancer and neurodegenerative disease (especially Alzheimer's), the shortcomings of traditional healthcare models, and the exciting advances in AI-powered health screening and intervention. Dr. Darshan Shah shares his personal transformation from a high-powered surgeon falling prey to chronic illness, to founding a nationwide longevity clinic, and becoming a leader in precision health. Together, Louisa and Dr. Shah breakdown what truly predicts long-term health, the value of modern biomarkers, and how technology, thoughtful lifestyle changes, and systems biology can give us the best odds against today’s biggest killers.

Dr. Shah’s Personal Health Crisis and the Pivot to Longevity (00:00–05:41)

• Origins in Medicine

  • Dr. Shah describes deep roots in Western surgery (general and reconstructive, notably for cancer patients):

    "I spent the first part of my career in surgery... a board-certified surgeon, 12 to 14 hours a day in the operating room...hospital care after surgery." (01:25)

• Surgeon, but Unhealthy

  • Paradox of being trained to heal others, but falling victim to chronic disease himself – uncontrolled diabetes, high blood pressure, and coup de sabre (autoimmune disorder):

    "I myself got very unhealthy being a surgeon...on high doses of methotrexate... just feeling horrible all the time." (00:00, 04:36)

• Discovery of Functional/Systems Medicine

  • The "aha" moment: differentiating the “science of disease” from the “science of health”; realizing Western medicine treats symptoms rather than root causes.

    "What I learned was a game changer—not just for my personal health, but for my mindset." (04:57) "Thank God we have Western medicine for acute cases, but the science of health is different and deeper." (05:13)

Multifactorial Disease: Autoimmunity, Stress, and Systems Biology (05:41–09:14)

• Explanation of Autoimmunity

  • Dr. Shah’s coup de sabre, a rare autoimmune disease attacking skin, bone, muscle—caused not by genes but likely by chronic stress and immune exhaustion:

    "It's not a defect of the immune system. It's an over-stressed, over-taxed immune system that is now malfunctioning." (07:02)

• Systems Biology vs. Specialization

  • Chronic and autoimmune diseases require an all-systems approach, not just a rheumatologist:

    "An autoimmune disease should have a rheumatologist, a neurologist, a gastroenterologist, a cardiologist—because it affects every system...” (08:03)

Blood Biomarkers: Moving Beyond the CBC and Lipids (09:14–16:59)

• Routine Bloodwork is Outdated

  • Traditional medicine’s standard panels only reveal problems when damage has already occurred; doesn’t proactively predict disease:

    "Traditional blood work...only useful for diagnosing bad problems...There's different blood work that we should be checking...can actually tell you if you're developing disease, sometimes decades before you develop it." (09:41)

• The Case for Proactive, Comprehensive Testing

  • Advocacy for exploring advanced biomarker tests routinely:
    • Inflammation
    • Insulin sensitivity & metabolic markers
    • Emerging brain and cancer biomarkers
  • Example of Function Health platform—Louisa shares she tests over 100 biomarkers every three to four months to catch “quiet issues.” (12:00–12:40)

The Cancer Epidemic: Screening, Early Detection, and New Tools (16:59–24:34)

• Colon Cancer as Case Study

  • Massive rise in colon cancer in the young, likely due to toxins, processed foods, microbiome disruption—not just better screening:

    "Colon cancer has become not a disease of old people anymore...10% in young people and this number is rising very quickly." (15:09)

  • Prevention: annual FIT tests (stool blood for colon cancer), Cologuard, and push for earlier colonoscopies—even if paying cash. (17:00–18:11)
  • “We have a screening modality, but we’re not using it effectively.” (19:54)

• Tech’s Next Frontier: MRI & Liquid Biopsy

  • Solid tumors: Full-body MRI scans (e.g., Prenuvo) for early detection, even before localized symptoms.
  • Blood-based cancer diagnostics: Grail test identifies trace tumor DNA in blood—moving from population health guidelines to “hyper preventive medicine.”

    “Cancer’s biggest enemy is being diagnosed as stage one—then you’re talking cure rates, not five-year survival rates.” (22:18)

Memorable Quote:
"There's 50 other common cancers out there that we're not screening for." – Dr. Shah (19:54)

Practical Protocols for Proactive Cancer and Brain Health Screening (24:34–29:35)

• Layered Screening Checklist:

  • Skin cancer: AI-enabled mole mapping, teledermatology apps
  • For women: Pap smears, mammograms (combine with ultrasound for dense breast tissue, full-body MRI for tumor search)
  • For men: Early PSA checks for prostate cancer
  • Both: Regular colonoscopies/endoscopies, advanced blood-based screens (Grail), full-body MRI

• Real-World Experience:

  • Louisa recounts personal breast cancer scare; emphasizes that these non-traditional symptoms must not be dismissed and comprehensive imaging is key. (26:36–27:15)

The New Era of Brain Biomarkers: Early Detection of Alzheimer’s (29:35–34:53)

• Blood Tests for Preclinical Alzheimer’s

  • Tests for phosphorylated tau (P-Tau 217, P-Tau 181) and amyloid proteins now correlate strongly with PET imaging of Alzheimer’s, available years before symptoms show.

    “No longer do we need to wait for symptoms or radiographic changes...we have a marker that correlates to what we’re seeing in the brain.” (30:12)

• Genetics and Risk Stratification

  • Test for APOE4 gene (1 copy = 4x risk, 2 copies = 16x risk); importantly, risk is modifiable, not a death sentence.

    “Genetic risk doesn’t really mean you will definitely get Alzheimer’s.” (33:21)

What You Can Do: Interventions for Brain and Vascular Health (34:53–41:18)

• Key Lifestyle/Medical Interventions

  • Exercise (esp. HIIT) for blood flow and nitric oxide
  • Treat high blood pressure aggressively; continuous blood pressure monitoring with FDA-approved devices (Helo)
    • Pro tip: Learn proper technique; track over time, not just at the doctor. (39:44–42:34)
  • Nitric oxide supplements: beetroot-based, red/near-infrared LED light therapy
  • Diet rich in omega-3s that cross the BBB, e.g., lyso-form DHA/EPA

• Blood Pressure & All-Cause Mortality

  • "Every increase you have—130 over 80 or higher—every 10 point increase increases your all-cause mortality by 15%." (40:26)

Blood Lipids & Cardiovascular-Brain Health Axis (43:17–53:32)

• The Case for APOB and LDL as Key Markers

  • APOB is the “main thing” to watch for overall vascular (including brain) health; get it below 80 where possible.
  • Dr. Shah advocates patients know their APOB, HSCRP, and hemoglobin A1C by heart.

• Statins, Ezetimibe, and Lifestyle

  • “Statins can be extremely useful...they’re anti-inflammatory as well. But we need to be thoughtful about prescribing, not just follow pharmaceutical incentives.” (49:20)
  • Lifestyle, fiber, Zetia (ezetimibe) work in parallel.

• Caution on Lab Interpretation

  • Double-check unexpected blood test results before panicking or starting treatment:

    "If there's something that's off that I'm going to institute a treatment protocol around...I always confirm with the second set of blood work." (51:15)

  • Be aware of differences between capillary vs. venous blood, and variability in lab processes.

Metabolic Markers, Insulin, and Alzheimer’s Connections (53:32–54:39)

• HOMA-IR and Insulin as Metabolic Predictors

  • "HOMA-IR is great, but fasting insulin is really, really powerful...can tell you way before a change in hemoglobin A1C." (52:56)
  • Aim for HbA1c < 5.2, fasting insulin < 8.

• Alzheimer's as "Type 3 Diabetes"?

  • Insulin resistance in the brain is a key risk factor.

GLP1 Drugs and Weight Loss: Risks and Nuance (54:39–57:15)

• New Wave of Metabolic Drugs
  • Discusses tirzepatide (dual GLP-1/GIP), emerging “triple” agonists—rapid, multifactorial weight loss.
  • But warns: rapid weight loss risks muscle loss, micronutrient deficiencies, skin laxity (“Ozempic face”).
  • Target: ~1lb per week is healthy loss.

The Real Goal: Quality of Life, Not Just Biomarkers (57:15–59:08)

• Balance vs. Biohacking Extremes
  • The importance of social connection, relationships, and living well—not just number-chasing or extreme regimens.

    "If your longevity biohacking routine is causing loneliness...what is the point?" (58:05)

Red Light Therapy, Tech Upgrades, and AI for Health (59:08–66:17)

• Red/Near-Infrared Light

  • Mechanisms: Boosts mitochondrial function, blood flow, nitric oxide, supports fertility, hair, and possibly longevity.
  • The new “immortal” red light bed also combines sound and PEMF; Dr. Shah saw a 50% acute jump in his HRV! (62:23)

• AI-Enabled Health Dashboards

  • Launching an AI “personal health board of directors”—integrates biomarker data, imaging, and contextual advice from multiple models, including “Dr. Shah” and “Dr. Nicola” personas. Securely combines lifestyle, prescription, and specialist recommendations for hyper-personalized insight.

    "You have a personal health board of directors...that will have access to your biomarkers, medical records...giving you proactive guidance." (65:06)

The Clearly Scan, AI Imaging, and the Future of Regeneration (66:17–71:19)

• Cardiac Imaging Revolution

  • Clearly scan: AI-enabled coronary CT angiogram that visualizes plaque type and burden (far beyond old angiograms)
  • Can track plaque regression with drugs (statins, ezetimibe, PCSK9i) and lifestyle (Mediterranean diet) (67:06–69:16)

• AI and Tissue Regeneration

  • Human trials now creating targeted Yamanaka factors (cellular reprogramming) using AI—potential nearby cures for vision loss, possibly even spinal damage or MS!

    "Using artificial intelligence, we can create Yamanaka factors...so we can very specifically regenerate the nerve itself." (70:27) "Could you imagine what that's going to do for the brain?" (70:54)

Notable Quotes & Memorable Moments

• “No longer do we need to wait for symptoms or radiographic changes...We have a marker that correlates to what we’re seeing in the brain.” – Dr. Shah (30:12)
• “Cancer’s biggest enemy is being diagnosed as stage one—then you’re talking cure rates, not five-year survival rates.” – Dr. Shah (22:18)
• “If your longevity biohacking routine is completely causing loneliness...what is the point?” – Dr. Shah (58:05)
• “Every increase you have—130 over 80 or higher—every 10 point increase increases your all-cause mortality by 15%.” – Dr. Shah (40:26)
• “You have a personal health board of directors, fully enabled with AI...giving you proactive guidance.” – Dr. Shah (65:06)
• “Using artificial intelligence, we can regenerate the nerve itself...Could you imagine what that's going to do for the brain?” – Dr. Shah (70:27–70:54)

Timestamps for Key Segments

• 00:00–05:41 – Dr. Shah’s personal crisis, move into longevity
• 05:41–09:14 – Autoimmunity, systems medicine, biology of disease
• 09:41–16:59 – Blood work beyond basics; new biomarkers
• 16:59–24:34 – Cancer spike in young, proactive screening strategies
• 29:35–34:53 – Preclinical Alzheimer’s, blood tests, genetic risk
• 34:53–41:18 – Actions to lower risk: exercise, blood pressure, nitric oxide, omega-3s
• 43:17–49:56 – APOB, LDL, statins, and interpreting blood work responsibly
• 53:32–54:39 – Metabolic health, insulin markers, Alzheimer’s as type 3 diabetes
• 54:39–57:15 – GLP1 drugs, importance of slow weight loss
• 57:15–59:08 – Quality of life—biohacking vs. living
• 59:08–66:17 – Red light therapy, new devices, and AI dashboards
• 66:17–71:19 – Clearly scan, advanced imaging, AI for tissue regeneration

Conclusion

For anyone serious about longevity, brain health, early cancer detection, and optimizing health trajectories, this episode offers a masterclass in the practical use of advanced biomarkers, the power of AI-driven health models, and the holistic, systems-based approach that true longevity demands. Dr. Shah and Louisa Nicola weave personal stories, actionable science, and future technology to help listeners not just add years to their life—but life to their years.